Your session is about to expire
← Back to Search
NB-001 for DiGeorge Syndrome
Study Summary
This trial is testing a new drug to see if it is safe and effective in treating children and adolescents with 22q11DS who also have neuropsychiatric conditions.
- DiGeorge Syndrome
Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Frequently Asked Questions
Has NB-001 attained regulatory authorization by the FDA?
"Having considered the data, our analysts at Power have assigned NB-001 a score of 2 on their safety scale. This is because there's evidence supporting its security but none attesting to its efficacy yet."
Are there currently opportunities for patient involvement in this trial?
"As per clinicaltrials.gov, this medical research is still searching for participants, with the study's initial post date being February 10th 2022 and its last update coming on November 16th of that same year."
Is there an opportunity to participate in this clinical experiment?
"This trial requires 34 participants with 22q11 deletion syndrome aged between 6 and 17."
Are there any healthcare facilities in this state currently conducting the trial?
"Eligible patients can enroll in this trial at the renowned Children's Hospital of Philadelphia (CHOP) located in Philadelphia, Pennsylvania, The esteemed Hospital for Sick Kids (SickKids) situated in Toronto, Ontario, Seattle Children's Hospital based in Seattle Washington and an additional 4 sites."
What is the current enrollment quota for this clinical investigation?
"This clinical trial requires the recruitment of 34 participants who match the parameters detailed in the inclusion criteria. Patients can take part from either Children's Hospital of Philadelphia (CHOP) Pennsylvania, or The Hospital for Sick Children (SickKids) Toronto, Ontario."
Is eligibility for this research experiment limited to adults?
"According to the trial parameters, children aged 6-17 are eligible for inclusion. In total, 374 studies have been conducted with minors while 983 clinical trials involve participants above 65 years old."
Share this study with friends
Copy Link
Messenger